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Brief Technique ReportsThe use of ventricular assist devices in pediatric patients with
univentricular heartsChristina J. VanderPluym, MD, Ivan M. Rebeyka, MD, FRCSC, David B. Ross, MD, FRCSC, and
Holger Buchholz, MD, Edmonton, Alberta, CanadaImproved survival outcomes for pediatric patients with ven-
tricular assist devices (VADs) has expanded their applica-
tion to complex univentricular cardiac lesions, including
patients with systemic-to-pulmonary shunts, bidirectional
cavopulmonary anastomoses (BCPAs), and total cavopul-
monary Fontan circulations. Although it is generally recog-
nized that complex cardiac anatomy is likely a significant
risk factor affectingVAD survival,1,2 there remains a paucity
of data examining the pediatric VAD experience with uni-
ventricular hearts.
CLINICAL SUMMARY
A 3-year-old 11.5-kg boy with mitral valve atresia, hypo-
plastic left ventricle, coarctation, and transposition of the
great vessels underwent an atrial septectomy with pulmo-
nary artery banding followed by a BCPA. An extracardiac
fenestrated Fontan procedure was performed at 3 years of
age. Postoperatively, he had increasing diastolic dysfunction
and thrombus formation in the extracardiac conduit necessi-
tating emergency revision back to a BCPA with extracorpo-
real membrane oxygenation. A 30-mL Berlin Heart Excor
Pediatric device was implanted with systemic right ventric-
ular and aortic cannulation on postoperative day 10. His
post-VAD implantation course was complicated by a left
subdural hemorrhage requiring decompressive craniotomy
and evacuation on day 15 despite adherence to a standard
anticoagulation protocol (the Edmonton anticoagulation
protocol). On days 38, 89, and 111, fibrin collections in
the outflow valve necessitated pump exchanges. The re-
mainder of his VAD course was uneventful for bleeding or
thromboembolic events. At 174 days after VAD implanta-
tion, he underwent successful transplantation and remains
well with no neurological sequelae.
Ten pediatric patients with VADs with single-ventricle
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588 The Journal of Thoracic and Cardiovascular Surg1987: 6 patients with Fontan circulations, 2 patients with
BCPAs, and 2 patients with a systemic-to-pulmonary shunt
(Table 1).3-12DISCUSSION
The paucity of published reports on VAD support in pa-
tients with single-ventricle anatomy precludes firm recom-
mendations regarding a preferred surgical technique and
postoperative management strategy. However, clinical expe-
rience to date can be used to formulate suggestions based on
the specific cardiac anatomy and physiology of the clinical
scenario.
Patients with shunt-dependent circulation can be
adequately supported with systemic ventricular inflow and
aortic outflow cannulation. However, the parallel circula-
tions usually require increased pump flow rates (200 mL $
kg1 $ min1) to accommodate the need for both pulmonary
and systemic perfusion and to maintain adequate oxygena-
tion. Inadequate systemic oxygenation caused by impaired
lung function can be addressed by placing a low-resistance
oxygenator within the outflow circuit.
Patients with BCPAs, as in this case report, can be sup-
ported with a systemic ventricular inflow and aortic outflow
cannulation technique. Thismanagement strategy has the po-
tential advantage of maintaining systemic cardiac output in
the presence of increased pulmonary vascular resistance at
the expense of lower systemic oxygen saturations. For this
reason, as with shunt-dependent circulation, a larger pump
size might be needed to meet end-organ oxygen demand.
BCPA physiology inherently unloads the hepatic, renal,
and splanchnic circulations by reducing venous hyperten-
sion and thereby decreasing the risk of multiorgan failure.
The failing Fontan circulation poses several surgical
options for VAD support that can be influenced by patient
specific circumstances. Ventricular dysfunction as the pri-
mary cause for failing Fontan circulation can be addressed
with single-pump VAD support of the systemic ventricle.
However, increased pulmonary vascular resistance might re-
quire an additional pump within the pulmonary circulation
to address systemic venous hypertension. In this situation
implantation of a pulmonary VAD requires revision of the
Fontan pathway for separation of the systemic venous and
pulmonary circulations. Notwithstanding the extensive na-
ture of the operation, there is an increased risk associated
with the creation of a totally VAD-dependent pulmonaryery c February 2011
TABLE 1. Ventricular assist devices in pediatric patients with single-ventricle anatomy
Case reports
Age
(y)
Weight
(kg) Anatomy
Surgical
procedure Device
Duration of
support (d) Complication Outcome
Matsuda
et al, 19883
10 16.0 Single-
ventricle
PS
Fontan Toyobo 7 MOF
Cardiac tamponade
Re-exploration 3 2
Death day 7
3 10.0 Single-
ventricle
PS
Systemic-to-
pulmonary
shunt (BT shunt)
Toyobo 5 Respiratory failure Death day 5
Sadeghi
et al, 20004
8 22.0 HLHS
MA
Fontan BVS 5000 8 Pump change
for fibrin
Transplantation
Nathan
et al, 20065
4 12.0 HLHS Fontan Berlin Heart 28 None Transplantation
Death caused by
graft failure
Chu et al, 20076 4 14.6 HLHS BCPA Berlin Heart 13 MOF
Bowel necrosis
Mesenteric,
hepatic, and renal
thrombi
Death day 13
Calvaruso
et al, 20077
10 32.0 Single RV
MA, PA
Fontan
(extracardiac
TCPC)
Berlin Heart 7 None Transplantation
Frazier et al, 20058 14 63.0 TA Fontan Centrifugal pump
and HeartMate I
45 ARF, HIT Transplantation
Russo et al, 20089 HRHS
Pearse et al, 200910 1.3 NS DORV, MA
d-TGA
Systemic-to-
pulmonary shunt
Berlin Heart 49 None Transplantation
Cardarelli
et al, 200911
1.5 NA HLHS Fontan
(extracardiac
TCPC)
Berlin Heart 179 Neuroimpairment
Change in pump
size
Decannulation
Irving et al, 200912 2.9 13 HLHS BCPA Berlin Heart 7 None Transplantation
PS, Pulmonary stenosis; MOF, multiorgan failure; BT, Blalock–Taussig; HLHS, hypoplastic left heart syndrome; MA, mitral atresia; BCPA, bidirectional cavopulmonary anasto-
moses; RV, right ventricle; PA, pulmonary artery; TCPC, total cavopulmonary; TA, tricuspid atresia; HRHS, hypoplastic right heart syndrome; ARF, acute renal failure; HIT,
heparin-induced thrombocytopenia; NA, not applicable; DORV, double-outlet right ventricle; d-TGA, transposition of the great arteries.
Brief Technique Reportscirculation. In the event of pump failure or a necessary pump
change, complete cessation of pulmonary flow and cardiac
output would occur.
For all types of palliated univentricular anatomy, strict ad-
herence to anticoagulation protocols with frequent monitor-
ing of the thromboelastogram, as opposed to reliance on
activated clotting times, has improved the rate of thrombotic
and hemorrhagic complications.13,14 Patients with single-
ventricle circulations are at increased risk of thromboem-
bolic events caused by liver dysfunction and coagulation
factor alterations, such as protein C deficiency. Vigilant sur-
veillance of neurological status is pivotal.
Improvement in survival to transplantation has been dem-
onstrated in recent years for all types of palliated single-
ventricle anatomy. This is likely attributable to refinement
in patient selection, surgical technique, and anticoagulation
management. Further experience and refinement of the pre-
implantation and postimplantation management is necessary
to improve overall outcomes in this challenging group of
patients.The Journal of Thoracic and CaReferences
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241-55.Pulmonary valve replacement in repaired tetralogy of Fallot by left
thoracotomy avoid ascending aorta injuryRoland Henaine, MD,a Naoki Yoshimura, MD,b Sylvie Di Filippo, MD, PhD,a and Jean Ninet, MD, PhD,a
Lyon, France, and Toyama, JapanWe report the follow-up of a patient born with tetralogy of
Fallot (TOF), which was corrected in childhood, who
required when he was 28-years-old a pulmonary valve
replacement (PVR) through a left anterolateral thoracotomy.
This case demonstrates the advantages of this approach of
simplicity and low risks of aortic lesions in particular.CLINICAL SUMMARY
In the neonatal period, this male patient underwent a Bla-
lock anastomosis through a left posterolateral thoracotomy.
When the patient was 2 years old, a second systemic–pulmo-
nary shunt through a right posterolateral thoracotomy was
performed. The total repair was performed when the patient
was 4 years old through a median sternotomy with extracor-
poreal circulation (ECC) and aortic clamping, with transan-
nular enlargement of an hypoplastic pulmonary arterial
trunk (PAT) with autologous pericardium. The outcome
was quite favorable, with normal growth and without any
functional symptoms, so medical monitoring was more
deliberately spaced.
At the age of 28 years, during an ordinary medical check-
up, the patient was asymptomatic. Furthermore, the Holter
electrocardiogram showed sinus rhythm, a complete rightbundle branch block, and QRS prolonged to 0.2 seconds.
Echocardiography showed significant pulmonary regurgita-
tion with dilated hypokinetic right ventricle. A computed to-
mographic scan showed dilatation of the PAT to 55 mm.
Magnetic resonance imaging confirmed the infundibular
dilatation, right ventricular ejection fraction of 25%, and
end-diastolic and end-systolic volumes of 172 mL/m2 and
128 mL/m2, respectively. The ascending aorta was dilated
to 44 mm and completely adherent to the posterior of the
sternum (Figure 1, A).
PVR was indicated. To avoid the sternotomy-associated
risk of damage to the ascending aorta, the preferred route
of left anterolateral thoracotomy was chosen, especially
because the PAT was just subcostal (Figure 1, B).
With the patient under general anesthesia, left femorofe-
moral ECC was initiated. A left anterolateral thoracotomy
was performed (Figure 2, A). After opening of the 4th in-
tercostal space with preservation of the left internal tho-
racic artery, the pericardium was exposed after release of
some of the lung adhesions. The PAT was easily exposed
because it was decompressed under ECC. A longitudinal
incision and resection of the pulmonary infundibular
excess allowed good exposure of the pulmonary ring.
A No. 25 Mitroflow bioprosthetic valve (Sorin SpA, Salug-
gia, Italy) was fixed with a 3-0 Prolene suture (Ethicon Inc,
Somerville, NJ; Figure 2, B). Direct closure of the PAT,
weaning from ECC, and closure of the thoracotomy were
conventional.
The patient was transferred to the intensive care unit,
extubated at 6 postoperative hours, and transferred to the
cardiology department. Echocardiography showed a well-
functioning bioprosthetic valve and absence of pericardial
effusion. The patient returned to his home 8 days after the
operation without functional symptoms.ery c February 2011
